ArticleClinical cancer research : an official journal of the American Association for Cancer Research2018

Inhibition of EphB4-Ephrin-B2 Signaling Enhances Response to Cetuximab-Radiation Therapy in Head and Neck Cancers.

Shilpa Bhatia et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.